Molecular cytogenics refers to the analysis of genetic materials in human beings by making use of molecular biology. These materials are analyzed to comprehend the purpose of chromosomes and genes.
This helps in the untimely detection of diseases. It also helps recognize the inclination of genes in causing illnesses. The molecular cytogenics market was worth almost USD 470 million in 2012.
The market is all set to register a healthy CAGR of about 23 percent in the coming years and will achieve a size of around USD 2 billion by 2019. The worldwide molecular cytogenics market is fuelled by increasing cancer cases, rise in health consciousness among people and growing activities of research and development.